Press Releases

Lexicon Pharmaceuticals to Participate in the Citi 15th Annual Biopharma Virtual Conference and the Wells Fargo 2020 Virtual Healthcare Conference	Sep 03, 2020
Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program	Jul 30, 2020
Lexicon Pharmaceuticals Enters Into Agreement with Tersera Therapeutics for the Sale of Xermelo	Jul 30, 2020
Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update	Jul 30, 2020
Lexicon Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call and Webcast on July 30, 2020	Jul 23, 2020
Lexicon Pharmaceuticals Announces Topline Phase 3 Data from Four Phase 3 Sotagliflozin Studies in Type 2 Diabetes	Jul 21, 2020
Lexicon Pharmaceuticals Announces Poster Presentations at the Virtual Cholangiocarcinoma Foundation Annual Conference	Jul 20, 2020
Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific Sessions	Jun 13, 2020
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	May 27, 2020
Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell Lines	May 13, 2020